NasdaqCM - Delayed Quote • USD
DarioHealth Corp. (DRIO)
At close: April 18 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.53 | -0.54 | -2.02 | -1.41 |
| Low Estimate | -0.59 | -0.58 | -2.2 | -1.61 |
| High Estimate | -0.47 | -0.5 | -1.84 | -1.22 |
| Year Ago EPS | -0.45 | -0.58 | -1.93 | -2.02 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 6.76M | 9.42M | 37.2M | 49.7M |
| Low Estimate | 5.95M | 8.1M | 32.79M | 41.37M |
| High Estimate | 7.57M | 10.74M | 41.61M | 58.03M |
| Year Ago Sales | 6.7M | 6.46M | 20.35M | 37.2M |
| Sales Growth (year/est) | 0.90% | 45.80% | 82.80% | 33.60% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.5 | -0.52 | -0.46 | -0.55 |
| EPS Actual | -0.45 | -0.58 | -0.49 | -0.5 |
| Difference | 0.05 | -0.06 | -0.03 | 0.05 |
| Surprise % | 10.00% | -11.50% | -6.50% | 9.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.53 | -0.54 | -2.02 | -1.41 |
| 7 Days Ago | -0.53 | -0.54 | -2.02 | -1.41 |
| 30 Days Ago | -0.45 | -0.34 | -1.55 | -1.61 |
| 60 Days Ago | -0.49 | -0.46 | -1.67 | -1.42 |
| 90 Days Ago | -0.46 | -0.44 | -1.67 | -1.52 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | -- | 2 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | DRIO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -17.80% | -- | -- | 0.80% |
| Next Qtr. | 6.90% | -- | -- | 9.60% |
| Current Year | -4.70% | -- | -- | 4.50% |
| Next Year | 30.20% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Stifel: Buy to Buy | 4/1/2024 |
| Maintains | Alliance Global Partners: Buy to Buy | 8/11/2023 |
| Maintains | Stifel: Buy to Buy | 7/25/2023 |
| Maintains | Craig-Hallum: Buy to Buy | 5/12/2023 |
| Maintains | Alliance Global Partners: Buy | 11/16/2022 |
| Maintains | Aegis Capital: Buy | 8/18/2022 |
Related Tickers
MDXH MDxHealth SA
2.2930
-2.01%
NOTV Inotiv, Inc.
4.7000
-13.28%
BDSX Biodesix, Inc.
1.2500
+3.31%
PSNL Personalis, Inc.
1.2100
+0.83%
DMTK DermTech, Inc.
0.5910
-0.17%
CSTL Castle Biosciences, Inc.
19.20
+1.91%
XWEL XWELL, Inc.
1.4000
+1.82%
ISPC iSpecimen Inc.
0.4210
+97.65%
MYGN Myriad Genetics, Inc.
18.51
-0.70%
FOAA.F FONAR Corporation
15.50
+0.65%